ReviewJournal for immunotherapy of cancer2026

Targeting macrophage-driven NK cell immunosuppression to improve cancer immunotherapy.

Anna Rita Redavid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.